Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-2-3
|
pubmed:databankReference |
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/M59815,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/M59816,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U07851,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U07852,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U07853,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/U24578
|
pubmed:abstractText |
Complement component C4 is an important protein of the classical, or antibody-mediated pathway of complement activation. Human C4 is located within the central region of the major histocompatibility complex on chromosome 6. Partial C4 deficiency has been associated with an increased susceptibility to immune complex disease. The strongest association with partial C4 deficiency is with systemic lupus erythematosus (SLE) and has been shown in most racial groups studied. Interestingly, Caucasian population studies have demonstrated an increased prevalence of C4A null alleles in SLE patients, in particular in association with the haplotype HLA-A1, B8, BfS, C4AQ0, C4B1, DR3. To investigate whether the C4 gene on this haplotype had any structural irregularities which may explain disease association, we sequenced the entire C4B gene from this haplotype. The results revealed that the gene encoded on the disease-associated haplotype carried major structural differences (when compared to C4A3) at the exonic level only in the C4d region. A high degree of conservation in both the 5' and 3' untranslated regions imply that disease associations will not be due to differential C4 expression as a result of regulatory differences between C4 genes. It appears likely that protein clearance mechanisms may account for the altered levels of C4 seen between different isotypes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0254-9670
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43-54
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8854088-Amino Acid Sequence,
pubmed-meshheading:8854088-Autoimmune Diseases,
pubmed-meshheading:8854088-Complement C4,
pubmed-meshheading:8854088-Genetic Linkage,
pubmed-meshheading:8854088-HLA-A1 Antigen,
pubmed-meshheading:8854088-HLA-B8 Antigen,
pubmed-meshheading:8854088-HLA-DR3 Antigen,
pubmed-meshheading:8854088-Haplotypes,
pubmed-meshheading:8854088-Humans,
pubmed-meshheading:8854088-Immune Complex Diseases,
pubmed-meshheading:8854088-Lupus Erythematosus, Systemic,
pubmed-meshheading:8854088-Molecular Sequence Data
|
pubmed:year |
1996
|
pubmed:articleTitle |
Comparative analysis of the disease-associated complement C4 gene from the HLA-A1, B8, DR3 haplotype.
|
pubmed:affiliation |
Department of Biochemistry, University of Western Australia, Nedlands, Australia.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|